What are the major opportunities in the Glomerulonephritis market? What are the strategies for the Glomerulonephritis market?

For detailed insights on the major opportunities and strategies in the Glomerulonephritis market, Read More

How does the Glomerulonephritis market relate to the overall economy and other similar markets?

For detailed insights on the key dynamics influencing the Glomerulonephritis market growth and SWOT analysis of the Glomerulonephritis industry, Read More

For detailed insights on the mergers and acquisitions in the Glomerulonephritis industry,

What are the key dynamics influencing the Glomerulonephritis market growth? SWOT analysis of the Glomerulonephritis market. Read More

Global Glomerulonephritis Market Report 2025

Item added to cart!

Published : December 2025

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Glomerulonephritis Global Market Report 2025

Name: Glomerulonephritis Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Type (Acute Glomerulonephritis, Chronic Glomerulonephritis), By Diagnosis (Urine And Blood Tests, Imaging Tests, Kidney Biopsy, Other Diagnosis), By Treatment (Medication, Surgery, Dialysis, Other Treatments), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels), By End-User (Hospitals, Specialty Clinics, Other End-Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Glomerulonephritis Market Overview

• Glomerulonephritis market size has reached to $11.06 billion in 2024

• Expected to grow to $14.03 billion in 2029 at a compound annual growth rate (CAGR) of 4.9%

• Growth Driver: Rising Prevalence Of Kidney Disorders Driving The Market Growth

• Market Trend: Breakthrough Non-Immunosuppressive Treatment For IgA Nephropathy

• North America was the largest region in 2024.

What Is Covered Under Glomerulonephritis Market?

Glomerulonephritis is a kidney disorder characterized by inflammation of the glomeruli, the tiny filters in the kidneys that remove waste and excess fluids from the blood. It can result from infections, autoimmune diseases, or other underlying conditions, leading to symptoms such as blood in urine, proteinuria, and swelling. If left untreated, it may progress to chronic kidney disease or kidney failure.

The main types of glomerulonephritis are acute glomerulonephritis and chronic glomerulonephritis. Acute glomerulonephritis is a sudden kidney inflammation that is often infection-induced and requires prompt treatment to prevent long-term damage. It is diagnosed by various diagnoses such as urine and blood tests, imaging tests, kidney biopsy, and others, and treated with several treatments, including medication, surgery, dialysis, and others. It is distributed through various distribution channels such as hospital pharmacies, retail pharmacies, and others and used by various end-users, including hospitals, specialty clinics, and others.

Glomerulonephritis Market Size and growth rate 2025 to 2029: Graph

What Is The Glomerulonephritis Market Size 2025 And Growth Rate?

The glomerulonephritis market size has grown strongly in recent years. It will grow from $11.06 billion in 2024 to $11.61 billion in 2025 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to the rising prevalence of kidney disorders, the prevalence of infections such as post-streptococcal glomerulonephritis, the rise in research and development, the increase in the incidence of kidney failure, and the growth in awareness regarding kidney diseases.

What Is The Glomerulonephritis Market Growth Forecast?

The glomerulonephritis market size is expected to see strong growth in the next few years. It will grow to $14.03 billion in 2029 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to increasing incidences of diabetes, an aging population, increasing investments in healthcare expenditure, an increase in the number of patients on dialysis, and rising cases of autoimmune diseases. Major trends in the forecast period include the launch of new treatments and therapies, advances in diagnostic technologies, novel therapeutics and therapies, collaboration between companies, and intravenous immunoglobulin therapy.

The forecast of 4.9% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. nephrology clinics by driving up the cost of immunosuppressants and renal biopsy needles sourced from Ireland and Japan, exacerbating kidney function decline and increasing nephrology treatment costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Glomerulonephritis Market Segmented?

1) By Type: Acute Glomerulonephritis, Chronic Glomerulonephritis

2) By Diagnosis: Urine And Blood Tests, Imaging Tests, Kidney Biopsy, Other Diagnosis

3) By Treatment: Medication, Surgery, Dialysis, Other Treatments

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels

5) By End-User: Hospitals, Specialty Clinics, Other End-Users

Subsegments:

1) By Acute Glomerulonephritis: Post-infectious Glomerulonephritis, IgA Nephropathy, Lupus Nephritis, Rapidly Progressive Glomerulonephritis (RPGN), Goodpasture Syndrome

2) By Chronic Glomerulonephritis: Focal Segmental Glomerulosclerosis (FSGS), Membranous Nephropathy, Minimal Change Disease, Alport Syndrome, Diabetic Nephropathy, Hypertensive Nephrosclerosis

What Is Driving The Glomerulonephritis Market? Rising Prevalence Of Kidney Disorders Driving The Market Growth

The rising prevalence of kidney disorders is expected to propel the growth of the glomerulonephritis market going forward. Kidney disorders refer to a range of conditions that affect the structure or function of the kidneys, leading to impaired filtration, waste removal, and fluid balance. The rising prevalence of kidney disorders is due to factors such as aging populations, rising rates of chronic diseases such as diabetes and hypertension, and lifestyle choices. Kidney disorders contribute to glomerulonephritis by triggering immune system dysfunction, chronic inflammation, or structural damage, leading to impaired kidney filtration and function. For instance, in December 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, chronic kidney disease (CKD) mortality rates increased by 4.2% in 2021 and 6.2% in 2022. In 2021–22, CKD was noted in around 2 million hospitalizations, representing 18% of all hospitalizations in Australia. Therefore, the rising prevalence of kidney disorders will drive the growth of the glomerulonephritis industry.

Who Are The Major Players In The Global Glomerulonephritis Market?

Major companies operating in the glomerulonephritis market are Pfizer Inc., F. Hoffmann-La Roche Ltd., AstraZeneca PLC, Novartis International AG, Eli Lilly and Company, Asahi Kasei Medical Co. Ltd., Boehringer Ingelheim International GmbH, DaVita Inc., Biogen Inc., Merit Medical Systems Inc., Apellis Pharmaceuticals Inc., MorphoSys AG, Travere Therapeutics Inc., Vera Therapeutics Inc., Calliditas Therapeutics AB, Omeros Corporation, Otsuka Pharmaceutical Co. Ltd., Aurinia Pharmaceuticals Inc., Alexion Pharmaceuticals Inc., NovelMed Therapeutics Inc.

What Are The Key Trends Of The Global Glomerulonephritis Market? Breakthrough Non-Immunosuppressive Treatment For IgA Nephropathy

Major companies operating in the glomerulonephritis market are focusing on developing advanced non-immunosuppressive treatments to address unmet medical needs and improve patient outcomes. Non-immunosuppressive treatments are therapies that do not weaken or suppress the immune system, aiming to treat conditions without compromising immune function. For instance, in September 2024, Travere Therapeutics Inc., a US-based biopharmaceutical company, introduced FILSPARI (sparsentan), approved by the Food and Drug Administration (FDA) for treating IgA nephropathy, a kidney disease. The drug is the only non-immunosuppressive treatment shown to significantly slow kidney function decline in these patients. FILSPARI’s approval marks a major breakthrough in the treatment of IgA nephropathy, which is the most common type of primary glomerulonephritis. The therapy offers a new option for patients who previously had limited choices. This approval highlights Travere's commitment to improving patient outcomes in kidney disease.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Glomerulonephritis Market? Rona Therapeutics And Keymed Biosciences Partner To Develop Sirna Therapeutics For Glomerulonephritis

In May 2023, Rona Therapeutics Inc., a China-based biopharmaceutical company, partnered with Keymed Biosciences Inc. to address the urgent need for new medicines. This partnership aims to develop first-in-class siRNA therapeutics for Glomerulonephritis. Keymed Biosciences Inc. is a China-based biotechnology company that develops treatments for glomerulonephritis.

What Is The Regional Outlook For The Global Glomerulonephritis Market?

North America was the largest region in the glomerulonephritis market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Glomerulonephritis Market?

The glomerulonephritis market consists of revenues earned by entities by providing services such as immunosuppressive therapy, blood pressure control, and kidney transplants. The market value includes the value of related goods sold by the service provider or included within the service offering. The glomerulonephritis market also includes sales of complement-level test kits, urine protein test kits, and medication. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Glomerulonephritis Industry?

The glomerulonephritis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the glomerulonephritis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Glomerulonephritis Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$11.61 billion
Revenue Forecast In 2034	$14.03 billion
Growth Rate	CAGR of 4.9% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The glomerulonephritis market covered in this report is segmented – 1) By Type: Acute Glomerulonephritis, Chronic Glomerulonephritis 2) By Diagnosis: Urine And Blood Tests, Imaging Tests, Kidney Biopsy, Other Diagnosis 3) By Treatment: Medication, Surgery, Dialysis, Other Treatments 4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels 5) By End-User: Hospitals, Specialty Clinics, Other End-Users Subsegments: 1) By Acute Glomerulonephritis: Post-infectious Glomerulonephritis, IgA Nephropathy, Lupus Nephritis, Rapidly Progressive Glomerulonephritis (RPGN), Goodpasture Syndrome 2) By Chronic Glomerulonephritis: Focal Segmental Glomerulosclerosis (FSGS), Membranous Nephropathy, Minimal Change Disease, Alport Syndrome, Diabetic Nephropathy, Hypertensive Nephrosclerosis
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., F. Hoffmann-La Roche Ltd., AstraZeneca PLC, Novartis International AG, Eli Lilly and Company, Asahi Kasei Medical Co. Ltd., Boehringer Ingelheim International GmbH, DaVita Inc., Biogen Inc., Merit Medical Systems Inc., Apellis Pharmaceuticals Inc., MorphoSys AG, Travere Therapeutics Inc., Vera Therapeutics Inc., Calliditas Therapeutics AB, Omeros Corporation, Otsuka Pharmaceutical Co. Ltd., Aurinia Pharmaceuticals Inc., Alexion Pharmaceuticals Inc., NovelMed Therapeutics Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Glomerulonephritis Market Characteristics

3. Glomerulonephritis Market Trends And Strategies

4. Glomerulonephritis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Glomerulonephritis Growth Analysis And Strategic Analysis Framework

5.1. Global Glomerulonephritis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Glomerulonephritis Market Growth Rate Analysis

5.4. Global Glomerulonephritis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Glomerulonephritis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Glomerulonephritis Total Addressable Market (TAM)

6. Glomerulonephritis Market Segmentation

6.1. Global Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Acute Glomerulonephritis

Chronic Glomerulonephritis

6.2. Global Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Urine And Blood Test

Imaging Tests

Kidney Biopsy

Other Diagnosis

6.3. Global Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Medication

Surgery

Dialysis

Other Treatments

6.4. Global Glomerulonephritis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacy

Retail Pharmacy

Other Distribution Channels

6.5. Global Glomerulonephritis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Specialty Clinics

Other End-Users

6.6. Global Glomerulonephritis Market, Sub-Segmentation Of Acute Glomerulonephritis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Post-infectious Glomerulonephritis

IgA Nephropathy

Lupus Nephritis

Rapidly Progressive Glomerulonephritis (RPGN)

Goodpasture Syndrome

6.7. Global Glomerulonephritis Market, Sub-Segmentation Of Chronic Glomerulonephritis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Focal Segmental Glomerulosclerosis (FSGS)

Membranous Nephropathy

Minimal Change Disease

Alport Syndrome

Diabetic Nephropathy

Hypertensive Nephrosclerosis

7. Glomerulonephritis Market Regional And Country Analysis

7.1. Global Glomerulonephritis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Glomerulonephritis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Glomerulonephritis Market

8.1. Asia-Pacific Glomerulonephritis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Glomerulonephritis Market

9.1. China Glomerulonephritis Market Overview

9.2. China Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Glomerulonephritis Market

10.1. India Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Glomerulonephritis Market

11.1. Japan Glomerulonephritis Market Overview

11.2. Japan Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Glomerulonephritis Market

12.1. Australia Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Glomerulonephritis Market

13.1. Indonesia Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Glomerulonephritis Market

14.1. South Korea Glomerulonephritis Market Overview

14.2. South Korea Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Glomerulonephritis Market

15.1. Western Europe Glomerulonephritis Market Overview

15.2. Western Europe Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Glomerulonephritis Market

16.1. UK Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Glomerulonephritis Market

17.1. Germany Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Glomerulonephritis Market

18.1. France Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Glomerulonephritis Market

19.1. Italy Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Glomerulonephritis Market

20.1. Spain Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Glomerulonephritis Market

21.1. Eastern Europe Glomerulonephritis Market Overview

21.2. Eastern Europe Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Glomerulonephritis Market

22.1. Russia Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Glomerulonephritis Market

23.1. North America Glomerulonephritis Market Overview

23.2. North America Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Glomerulonephritis Market

24.1. USA Glomerulonephritis Market Overview

24.2. USA Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Glomerulonephritis Market

25.1. Canada Glomerulonephritis Market Overview

25.2. Canada Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Glomerulonephritis Market

26.1. South America Glomerulonephritis Market Overview

26.2. South America Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Glomerulonephritis Market

27.1. Brazil Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Glomerulonephritis Market

28.1. Middle East Glomerulonephritis Market Overview

28.2. Middle East Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Glomerulonephritis Market

29.1. Africa Glomerulonephritis Market Overview

29.2. Africa Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Glomerulonephritis Market Competitive Landscape And Company Profiles

30.1. Glomerulonephritis Market Competitive Landscape

30.2. Glomerulonephritis Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

31. Glomerulonephritis Market Other Major And Innovative Companies

31.1. Asahi Kasei Medical Co. Ltd.

31.2. Boehringer Ingelheim International GmbH

31.3. DaVita Inc.

31.4. Biogen Inc.

31.5. Merit Medical Systems Inc.

31.6. Apellis Pharmaceuticals Inc.

31.7. MorphoSys AG

31.8. Travere Therapeutics Inc.

31.9. Vera Therapeutics Inc.

31.10. Calliditas Therapeutics AB

31.11. Omeros Corporation

31.12. Otsuka Pharmaceutical Co. Ltd.

31.13. Aurinia Pharmaceuticals Inc.

31.14. Alexion Pharmaceuticals Inc.

31.15. NovelMed Therapeutics Inc.

32. Global Glomerulonephritis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Glomerulonephritis Market

34. Recent Developments In The Glomerulonephritis Market

35. Glomerulonephritis Market High Potential Countries, Segments and Strategies

35.1 Glomerulonephritis Market In 2029 - Countries Offering Most New Opportunities

35.2 Glomerulonephritis Market In 2029 - Segments Offering Most New Opportunities

35.3 Glomerulonephritis Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Glomerulonephritis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Glomerulonephritis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Glomerulonephritis Market, Sub-Segmentation Of Acute Glomerulonephritis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Glomerulonephritis Market, Sub-Segmentation Of Chronic Glomerulonephritis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Glomerulonephritis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Glomerulonephritis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Pfizer Inc. Financial Performance

Table 79: F. Hoffmann-La Roche Ltd. Financial Performance

Table 80: AstraZeneca PLC Financial Performance

Table 81: Novartis International AG Financial Performance

Table 82: Eli Lilly and Company Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Glomerulonephritis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Glomerulonephritis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Glomerulonephritis Market, Sub-Segmentation Of Acute Glomerulonephritis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Glomerulonephritis Market, Sub-Segmentation Of Chronic Glomerulonephritis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Glomerulonephritis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Glomerulonephritis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Pfizer Inc. Financial Performance

Figure 79: F. Hoffmann-La Roche Ltd. Financial Performance

Figure 80: AstraZeneca PLC Financial Performance

Figure 81: Novartis International AG Financial Performance

Figure 82: Eli Lilly and Company Financial Performance

Intestinal Fistula Treatment Market Overview 2025: Competitive Shifts, Forecast Models, and Emerging Opportunities

Next-Gen Invasive Aspergillosis Therapeutics : Market Forecast, Transformation, and Long-Term Trajectories

Iron Deficiency Anemia Growth Trajectory: Key Forecasts and Strategic Insights

Lewy Body Dementia Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Kidney Disease Global Market Report 2025 – By Treatment (Medication, Dialysis, Surgery, Other Treatments), By Indication (Acute Kidney Injury, Chronic Kidney Disease, End-Stage Renal Disease, Other Indication), By Route ...

Chronic Kidney Disease Global Market Report 2025 – By Diagnosis (Blood Test, Urine Test, Imaging Test, Kidney Biopsy), By Treatment (Drugs, Dialysis, Kidney Transplant, ACE Inhibitors, Blood Test, Other Treatments), By R...

Diabetic Kidney Disease Global Market Report 2025 – By Type (Type 1 Diabetes, Type 2 Diabetes), By Treatment (Angiotensin Receptor Blockers (Arbs), Angiotensin-Converting Enzyme (Ace) Inhibitors, Antioxidant Inflammation...

Rare Kidney Diseases Global Market Report 2025 – By Target Indication (IgA Nephropathy, Lupus Nephritis, Focal Segmental Glomerular Sclerosis, Membranous Nephropathy, C3 Glomerulopathy, Other Target Indications), By Type...

Renal Biomarkers Global Market Report 2025 – By Biomarker Type (Functional Biomarker, Up Regulated Protein, Other Biomarker Types), By Diagnostic Technique (Enzyme-Linked Immunosorbent Assay, Particle-Enhanced Turbidimet...

Veterinary Renal Disease Global Market Report 2025 – By Type (Diagnosis, Treatment), By Animal Type (Canine, Feline, Bovine, Equine, Other Animal Types), By Indication (Renal Failure, Chronic Kidney Disease (CKD), Renal ...

Giant-Cell Arteritis Global Market Report 2025 – By Therapeutics (Prednisone, Methotrexate, Tocilizumab, Aspirin), By Mechanism Of Action (Corticosteroids, Immunosuppressive Agents, Anticoagulants, Other Mechanisms Of Ac...

Frequently Asked Questions

What is the definition of the Glomerulonephritis market?

How will the Glomerulonephritis market drivers and restraints affect the market dynamics? What forces will shape the Glomerulonephritis industry going forward?

The market major growth driver - Rising Prevalence Of Kidney Disorders Driving The Market Growth. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Glomerulonephritis market?

The glomerulonephritis market size has grown steadily in recent years. It will grow from $11.06 billion in 2024 to $11.61 billion in 2025 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to the rising prevalence of kidney disorders, the prevalence of infections such as post-streptococcal glomerulonephritis, the rise in research and development, the increase in the incidence of kidney failure, and the growth in awareness regarding kidney diseases. The glomerulonephritis market size is expected to see steady growth in the next few years. It will grow to " $14.03 billion in 2029 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to increasing incidences of diabetes, an aging population, increasing investments in healthcare expenditure, an increase in the number of patients on dialysis, and rising cases of autoimmune diseases. Major trends in the forecast period include the launch of new treatments and therapies, advances in diagnostic technologies, novel therapeutics and therapies, collaboration between companies, and intravenous immunoglobulin therapy. For further insights on this market, request a sample here

How is the Glomerulonephritis market segmented?

The glomerulonephritismarket covered in this report is segmented –
1) By Type: Acute Glomerulonephritis; Chronic Glomerulonephritis
2) By Diagnosis: Urine And Blood Tests; Imaging Tests; Kidney Biopsy; Other Diagnosis
3) By Treatment: Medication; Surgery; Dialysis; Other Treatments
4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Other Distribution Channels
5) By End-User: Hospitals; Specialty Clinics; Other End-Users Subsegments:
1) By Acute Glomerulonephritis: Post-infectious Glomerulonephritis; IgA Nephropathy; Lupus Nephritis; Rapidly Progressive Glomerulonephritis (RPGN); Goodpasture Syndrome
2) By Chronic Glomerulonephritis: Focal Segmental Glomerulosclerosis (FSGS); Membranous Nephropathy; Minimal Change Disease; Alport Syndrome; Diabetic Nephropathy; Hypertensive Nephrosclerosis For further insights on this market, request a sample here

Which region has the largest share of the Glomerulonephritis market? What are the other regions covered in the report?

North America was the largest region in the glomerulonephritis market in 2024. The regions covered in the glomerulonephritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Glomerulonephritis market?

What are the key trends in the Glomerulonephritis market?

Major trends in this market include Breakthrough Non-Immunosuppressive Treatment For IgA Nephropathy. For further insights on this market, request a sample here.